“When we just look at immediate financial returns, oftentimes we miss the full picture of the value that gets created.” - Rita Sallam, Gartner Distinguished VP Analyst, Data and Analytics

By 2025, nearly a third of GenAI projects will be abandoned due largely to unclear business value. To prove GenAI’s transformative value to executives and CFOs, this episode’s guest offers an insider’s perspective. Rita Sallam is a Distinguished VP Analyst for data and analytics and a former CFO. Her experience and expertise provide critical insights for:

Projecting the total cost of GenAI via use cases (3:50)
Managing costs as the pilot phase moves to implementation (8:24)
Calculating your GenAI budget (12:00)
Measuring GenAI ROI (Spoiler: It’s not cost reduction) (14:43)
Convincing CFOs that GenAI’s value may not appear on the balance sheet (21:25)

Trump’s MAGA Pundits SQUIRM as PRESSURE Mounts After ICE Crackdown